Global Long-acting PrEP Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Long-acting PrEP market size was valued at US$ 321 million in 2025 and is forecast to a readjusted size of US$ 836 million by 2032 with a CAGR of 14.7% during review period.
Long-acting PrEP refers to HIV pre-exposure prophylaxis delivered through formulations or delivery systems that sustain protective drug exposure over extended periods, shifting prevention from daily or event-driven pill-taking to dosing or device replacement at monthly, quarterly, semiannual, or even longer intervals. The primary problem it addresses is the real-world persistence and access gap seen with oral PrEP: many people who would benefit from prevention struggle with continuous daily adherence, timely refills, discreet storage and use, or consistent engagement with care, and fluctuating risk patterns can make stop?start cycles especially prone to protection gaps. By reducing dosing frequency and the day-to-day behavioral burden, long-acting PrEP aims to increase the likelihood of uninterrupted protection while enabling prevention to be packaged more naturally with follow-up, testing, and broader sexual health services. Its product history can be viewed in stages: oral PrEP first established efficacy and became embedded in guidelines and practice; the field then leveraged advances from long-acting HIV treatment?such as micro-/nano-crystal depot technologies, stable injectable formulations, aseptic manufacturing, and cold-chain logistics?to enable the first wave of long-acting PrEP commercialization; and current development is focused on extending duration and diversifying modalities, including longer-interval small-molecule injections, controlled-release implants, and biologics-based approaches with the potential for even less frequent administration. Upstream, long-acting PrEP depends on both conventional pharmaceutical inputs and a more demanding formulation-and-device supply chain: APIs and key intermediates; chemical reagents, catalysts, and solvents; injection- or implant-grade excipients (surfactants, stabilizers, buffers, water for injection, and medical-grade polymers); and the components and consumables required for aseptic production and delivery (injectable-grade glass containers, elastomer stoppers/plungers, seals, needles and safety injection devices, prefilled systems, sterilizing filters, single-use tubing and filling sets, labels, and cold-chain packaging), supported by specialized suppliers providing aseptic fill-finish, sterilization validation, temperature-controlled transport, and quality-system services.In 2025, the global production capacity of long-acting PrEP reached 150,000 doses, while total sales amounted to 117,200 doses. The average selling price was USD 2,660 per dose, and manufacturers? gross margins ranged between 60% and 70%.
The current long-acting PrEP market is characterized by rising awareness and uneven delivery capacity. Clinical and public health stakeholders increasingly view long-acting options as essential for reaching people who struggle with persistence on oral regimens, yet uptake is often constrained by the practical realities of care delivery?reliable follow-up pathways, standardized testing and risk assessment, trained personnel, and tighter inventory and cold-chain discipline. Differences across countries and regions in reimbursement design, provider networks, stigma, and access for priority populations create markedly different adoption trajectories. As a result, competition today is as much about building a sustainable service model as it is about the medicine itself: streamlined patient journeys, integration with sexual health services, community-based outreach, and models tailored to younger or highly mobile groups.
Looking forward, the market is likely to evolve through a combination of technology diversification and service decentralization. On the technology side, development efforts are converging on longer dosing intervals, fewer touchpoints with the health system, improved tolerability, and more flexible user options, with multiple modalities advancing in parallel and enabling differentiated product portfolios. In parallel, real-world success will depend increasingly on complementary delivery innovations?risk-stratified follow-up that avoids unnecessary visits, expanded roles for community providers and pharmacies, digital support for continuity, and smoother ?start?pause?restart? pathways. The market will also become more segmented, with different prevention packages emerging for different exposure patterns and social contexts, shifting differentiation from efficacy alone toward sustained user experience and system efficiency.
Key drivers include the alignment of public health priorities with user preferences for prevention that is easier to maintain and more discreet, along with steady progress in formulation and manufacturing that supports broader scale-up. Payers and providers also have growing incentives to adopt models that emphasize outcomes and continuity rather than repeated transactional visits. At the same time, barriers remain substantial: reliance on clinical infrastructure can slow decentralization, concerns about long drug ?tail,? injection-site effects, and reversibility can deter initiation for some, and stigma and privacy dynamics continue to influence both demand and engagement. Supply-side complexity?aseptic manufacturing, cold-chain logistics, and reliable component availability?adds another layer of fragility. Ultimately, expansion is likely to be strongest where payment policy, delivery networks, and community engagement reinforce one another, enabling long-acting prevention to function as a durable system rather than a standalone intervention.
This report is a detailed and comprehensive analysis for global Long-acting PrEP market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Long-acting PrEP market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Long-acting PrEP market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Long-acting PrEP market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Long-acting PrEP market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Long-acting PrEP market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Long-acting PrEP product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Long-acting PrEP, with price, sales quantity, revenue, and global market share of Long-acting PrEP from 2021 to 2026.
Chapter 3, the Long-acting PrEP competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Long-acting PrEP breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Long-acting PrEP market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Long-acting PrEP.
Chapter 14 and 15, to describe Long-acting PrEP sales channel, distributors, customers, research findings and conclusion.
Long-acting PrEP refers to HIV pre-exposure prophylaxis delivered through formulations or delivery systems that sustain protective drug exposure over extended periods, shifting prevention from daily or event-driven pill-taking to dosing or device replacement at monthly, quarterly, semiannual, or even longer intervals. The primary problem it addresses is the real-world persistence and access gap seen with oral PrEP: many people who would benefit from prevention struggle with continuous daily adherence, timely refills, discreet storage and use, or consistent engagement with care, and fluctuating risk patterns can make stop?start cycles especially prone to protection gaps. By reducing dosing frequency and the day-to-day behavioral burden, long-acting PrEP aims to increase the likelihood of uninterrupted protection while enabling prevention to be packaged more naturally with follow-up, testing, and broader sexual health services. Its product history can be viewed in stages: oral PrEP first established efficacy and became embedded in guidelines and practice; the field then leveraged advances from long-acting HIV treatment?such as micro-/nano-crystal depot technologies, stable injectable formulations, aseptic manufacturing, and cold-chain logistics?to enable the first wave of long-acting PrEP commercialization; and current development is focused on extending duration and diversifying modalities, including longer-interval small-molecule injections, controlled-release implants, and biologics-based approaches with the potential for even less frequent administration. Upstream, long-acting PrEP depends on both conventional pharmaceutical inputs and a more demanding formulation-and-device supply chain: APIs and key intermediates; chemical reagents, catalysts, and solvents; injection- or implant-grade excipients (surfactants, stabilizers, buffers, water for injection, and medical-grade polymers); and the components and consumables required for aseptic production and delivery (injectable-grade glass containers, elastomer stoppers/plungers, seals, needles and safety injection devices, prefilled systems, sterilizing filters, single-use tubing and filling sets, labels, and cold-chain packaging), supported by specialized suppliers providing aseptic fill-finish, sterilization validation, temperature-controlled transport, and quality-system services.In 2025, the global production capacity of long-acting PrEP reached 150,000 doses, while total sales amounted to 117,200 doses. The average selling price was USD 2,660 per dose, and manufacturers? gross margins ranged between 60% and 70%.
The current long-acting PrEP market is characterized by rising awareness and uneven delivery capacity. Clinical and public health stakeholders increasingly view long-acting options as essential for reaching people who struggle with persistence on oral regimens, yet uptake is often constrained by the practical realities of care delivery?reliable follow-up pathways, standardized testing and risk assessment, trained personnel, and tighter inventory and cold-chain discipline. Differences across countries and regions in reimbursement design, provider networks, stigma, and access for priority populations create markedly different adoption trajectories. As a result, competition today is as much about building a sustainable service model as it is about the medicine itself: streamlined patient journeys, integration with sexual health services, community-based outreach, and models tailored to younger or highly mobile groups.
Looking forward, the market is likely to evolve through a combination of technology diversification and service decentralization. On the technology side, development efforts are converging on longer dosing intervals, fewer touchpoints with the health system, improved tolerability, and more flexible user options, with multiple modalities advancing in parallel and enabling differentiated product portfolios. In parallel, real-world success will depend increasingly on complementary delivery innovations?risk-stratified follow-up that avoids unnecessary visits, expanded roles for community providers and pharmacies, digital support for continuity, and smoother ?start?pause?restart? pathways. The market will also become more segmented, with different prevention packages emerging for different exposure patterns and social contexts, shifting differentiation from efficacy alone toward sustained user experience and system efficiency.
Key drivers include the alignment of public health priorities with user preferences for prevention that is easier to maintain and more discreet, along with steady progress in formulation and manufacturing that supports broader scale-up. Payers and providers also have growing incentives to adopt models that emphasize outcomes and continuity rather than repeated transactional visits. At the same time, barriers remain substantial: reliance on clinical infrastructure can slow decentralization, concerns about long drug ?tail,? injection-site effects, and reversibility can deter initiation for some, and stigma and privacy dynamics continue to influence both demand and engagement. Supply-side complexity?aseptic manufacturing, cold-chain logistics, and reliable component availability?adds another layer of fragility. Ultimately, expansion is likely to be strongest where payment policy, delivery networks, and community engagement reinforce one another, enabling long-acting prevention to function as a durable system rather than a standalone intervention.
This report is a detailed and comprehensive analysis for global Long-acting PrEP market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Long-acting PrEP market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Long-acting PrEP market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Long-acting PrEP market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Long-acting PrEP market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Long-acting PrEP
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Long-acting PrEP market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Cabotegravir
- Lenacapavir
- Other
- Short-interval Injections
- Monthly Injections
- Quarterly Injections
- Original Drug
- Generic Drug
- Hospital
- Clinic
- Other
- Gilead Sciences
- ViiV Healthcare
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Long-acting PrEP product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Long-acting PrEP, with price, sales quantity, revenue, and global market share of Long-acting PrEP from 2021 to 2026.
Chapter 3, the Long-acting PrEP competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Long-acting PrEP breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Long-acting PrEP market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Long-acting PrEP.
Chapter 14 and 15, to describe Long-acting PrEP sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Long-acting PrEP Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Cabotegravir
1.3.3 Lenacapavir
1.3.4 Other
1.4 Market Analysis by Dosing Interval
1.4.1 Overview: Global Long-acting PrEP Consumption Value by Dosing Interval: 2021 Versus 2025 Versus 2032
1.4.2 Short-interval Injections
1.4.3 Monthly Injections
1.4.4 Quarterly Injections
1.5 Market Analysis by Drug Properties
1.5.1 Overview: Global Long-acting PrEP Consumption Value by Drug Properties: 2021 Versus 2025 Versus 2032
1.5.2 Original Drug
1.5.3 Generic Drug
1.6 Market Analysis by Application
1.6.1 Overview: Global Long-acting PrEP Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospital
1.6.3 Clinic
1.6.4 Other
1.7 Global Long-acting PrEP Market Size & Forecast
1.7.1 Global Long-acting PrEP Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Long-acting PrEP Sales Quantity (2021-2032)
1.7.3 Global Long-acting PrEP Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business
2.1.3 Gilead Sciences Long-acting PrEP Product and Services
2.1.4 Gilead Sciences Long-acting PrEP Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Gilead Sciences Recent Developments/Updates
2.2 ViiV Healthcare
2.2.1 ViiV Healthcare Details
2.2.2 ViiV Healthcare Major Business
2.2.3 ViiV Healthcare Long-acting PrEP Product and Services
2.2.4 ViiV Healthcare Long-acting PrEP Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 ViiV Healthcare Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: LONG-ACTING PREP BY MANUFACTURER
3.1 Global Long-acting PrEP Sales Quantity by Manufacturer (2021-2026)
3.2 Global Long-acting PrEP Revenue by Manufacturer (2021-2026)
3.3 Global Long-acting PrEP Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Long-acting PrEP by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Long-acting PrEP Manufacturer Market Share in 2025
3.4.3 Top 6 Long-acting PrEP Manufacturer Market Share in 2025
3.5 Long-acting PrEP Market: Overall Company Footprint Analysis
3.5.1 Long-acting PrEP Market: Region Footprint
3.5.2 Long-acting PrEP Market: Company Product Type Footprint
3.5.3 Long-acting PrEP Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Long-acting PrEP Market Size by Region
4.1.1 Global Long-acting PrEP Sales Quantity by Region (2021-2032)
4.1.2 Global Long-acting PrEP Consumption Value by Region (2021-2032)
4.1.3 Global Long-acting PrEP Average Price by Region (2021-2032)
4.2 North America Long-acting PrEP Consumption Value (2021-2032)
4.3 Europe Long-acting PrEP Consumption Value (2021-2032)
4.4 Asia-Pacific Long-acting PrEP Consumption Value (2021-2032)
4.5 South America Long-acting PrEP Consumption Value (2021-2032)
4.6 Middle East & Africa Long-acting PrEP Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Long-acting PrEP Sales Quantity by Type (2021-2032)
5.2 Global Long-acting PrEP Consumption Value by Type (2021-2032)
5.3 Global Long-acting PrEP Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Long-acting PrEP Sales Quantity by Application (2021-2032)
6.2 Global Long-acting PrEP Consumption Value by Application (2021-2032)
6.3 Global Long-acting PrEP Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Long-acting PrEP Sales Quantity by Type (2021-2032)
7.2 North America Long-acting PrEP Sales Quantity by Application (2021-2032)
7.3 North America Long-acting PrEP Market Size by Country
7.3.1 North America Long-acting PrEP Sales Quantity by Country (2021-2032)
7.3.2 North America Long-acting PrEP Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Long-acting PrEP Sales Quantity by Type (2021-2032)
8.2 Europe Long-acting PrEP Sales Quantity by Application (2021-2032)
8.3 Europe Long-acting PrEP Market Size by Country
8.3.1 Europe Long-acting PrEP Sales Quantity by Country (2021-2032)
8.3.2 Europe Long-acting PrEP Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Long-acting PrEP Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Long-acting PrEP Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Long-acting PrEP Market Size by Region
9.3.1 Asia-Pacific Long-acting PrEP Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Long-acting PrEP Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Long-acting PrEP Sales Quantity by Type (2021-2032)
10.2 South America Long-acting PrEP Sales Quantity by Application (2021-2032)
10.3 South America Long-acting PrEP Market Size by Country
10.3.1 South America Long-acting PrEP Sales Quantity by Country (2021-2032)
10.3.2 South America Long-acting PrEP Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Long-acting PrEP Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Long-acting PrEP Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Long-acting PrEP Market Size by Country
11.3.1 Middle East & Africa Long-acting PrEP Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Long-acting PrEP Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Long-acting PrEP Market Drivers
12.2 Long-acting PrEP Market Restraints
12.3 Long-acting PrEP Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Long-acting PrEP and Key Manufacturers
13.2 Manufacturing Costs Percentage of Long-acting PrEP
13.3 Long-acting PrEP Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Long-acting PrEP Typical Distributors
14.3 Long-acting PrEP Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Long-acting PrEP Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Cabotegravir
1.3.3 Lenacapavir
1.3.4 Other
1.4 Market Analysis by Dosing Interval
1.4.1 Overview: Global Long-acting PrEP Consumption Value by Dosing Interval: 2021 Versus 2025 Versus 2032
1.4.2 Short-interval Injections
1.4.3 Monthly Injections
1.4.4 Quarterly Injections
1.5 Market Analysis by Drug Properties
1.5.1 Overview: Global Long-acting PrEP Consumption Value by Drug Properties: 2021 Versus 2025 Versus 2032
1.5.2 Original Drug
1.5.3 Generic Drug
1.6 Market Analysis by Application
1.6.1 Overview: Global Long-acting PrEP Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospital
1.6.3 Clinic
1.6.4 Other
1.7 Global Long-acting PrEP Market Size & Forecast
1.7.1 Global Long-acting PrEP Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Long-acting PrEP Sales Quantity (2021-2032)
1.7.3 Global Long-acting PrEP Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business
2.1.3 Gilead Sciences Long-acting PrEP Product and Services
2.1.4 Gilead Sciences Long-acting PrEP Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Gilead Sciences Recent Developments/Updates
2.2 ViiV Healthcare
2.2.1 ViiV Healthcare Details
2.2.2 ViiV Healthcare Major Business
2.2.3 ViiV Healthcare Long-acting PrEP Product and Services
2.2.4 ViiV Healthcare Long-acting PrEP Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 ViiV Healthcare Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: LONG-ACTING PREP BY MANUFACTURER
3.1 Global Long-acting PrEP Sales Quantity by Manufacturer (2021-2026)
3.2 Global Long-acting PrEP Revenue by Manufacturer (2021-2026)
3.3 Global Long-acting PrEP Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Long-acting PrEP by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Long-acting PrEP Manufacturer Market Share in 2025
3.4.3 Top 6 Long-acting PrEP Manufacturer Market Share in 2025
3.5 Long-acting PrEP Market: Overall Company Footprint Analysis
3.5.1 Long-acting PrEP Market: Region Footprint
3.5.2 Long-acting PrEP Market: Company Product Type Footprint
3.5.3 Long-acting PrEP Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Long-acting PrEP Market Size by Region
4.1.1 Global Long-acting PrEP Sales Quantity by Region (2021-2032)
4.1.2 Global Long-acting PrEP Consumption Value by Region (2021-2032)
4.1.3 Global Long-acting PrEP Average Price by Region (2021-2032)
4.2 North America Long-acting PrEP Consumption Value (2021-2032)
4.3 Europe Long-acting PrEP Consumption Value (2021-2032)
4.4 Asia-Pacific Long-acting PrEP Consumption Value (2021-2032)
4.5 South America Long-acting PrEP Consumption Value (2021-2032)
4.6 Middle East & Africa Long-acting PrEP Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Long-acting PrEP Sales Quantity by Type (2021-2032)
5.2 Global Long-acting PrEP Consumption Value by Type (2021-2032)
5.3 Global Long-acting PrEP Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Long-acting PrEP Sales Quantity by Application (2021-2032)
6.2 Global Long-acting PrEP Consumption Value by Application (2021-2032)
6.3 Global Long-acting PrEP Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Long-acting PrEP Sales Quantity by Type (2021-2032)
7.2 North America Long-acting PrEP Sales Quantity by Application (2021-2032)
7.3 North America Long-acting PrEP Market Size by Country
7.3.1 North America Long-acting PrEP Sales Quantity by Country (2021-2032)
7.3.2 North America Long-acting PrEP Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Long-acting PrEP Sales Quantity by Type (2021-2032)
8.2 Europe Long-acting PrEP Sales Quantity by Application (2021-2032)
8.3 Europe Long-acting PrEP Market Size by Country
8.3.1 Europe Long-acting PrEP Sales Quantity by Country (2021-2032)
8.3.2 Europe Long-acting PrEP Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Long-acting PrEP Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Long-acting PrEP Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Long-acting PrEP Market Size by Region
9.3.1 Asia-Pacific Long-acting PrEP Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Long-acting PrEP Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Long-acting PrEP Sales Quantity by Type (2021-2032)
10.2 South America Long-acting PrEP Sales Quantity by Application (2021-2032)
10.3 South America Long-acting PrEP Market Size by Country
10.3.1 South America Long-acting PrEP Sales Quantity by Country (2021-2032)
10.3.2 South America Long-acting PrEP Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Long-acting PrEP Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Long-acting PrEP Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Long-acting PrEP Market Size by Country
11.3.1 Middle East & Africa Long-acting PrEP Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Long-acting PrEP Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Long-acting PrEP Market Drivers
12.2 Long-acting PrEP Market Restraints
12.3 Long-acting PrEP Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Long-acting PrEP and Key Manufacturers
13.2 Manufacturing Costs Percentage of Long-acting PrEP
13.3 Long-acting PrEP Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Long-acting PrEP Typical Distributors
14.3 Long-acting PrEP Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Polyurethane Latex Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Polyurethane Latex Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. BASF Basic Information, Manufacturing Base and Competitors
Table 4. BASF Major Business
Table 5. BASF Polyurethane Latex Product and Services
Table 6. BASF Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. BASF Recent Developments/Updates
Table 8. Bayer Basic Information, Manufacturing Base and Competitors
Table 9. Bayer Major Business
Table 10. Bayer Polyurethane Latex Product and Services
Table 11. Bayer Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Bayer Recent Developments/Updates
Table 13. DSM Basic Information, Manufacturing Base and Competitors
Table 14. DSM Major Business
Table 15. DSM Polyurethane Latex Product and Services
Table 16. DSM Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. DSM Recent Developments/Updates
Table 18. Chemtura Basic Information, Manufacturing Base and Competitors
Table 19. Chemtura Major Business
Table 20. Chemtura Polyurethane Latex Product and Services
Table 21. Chemtura Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Chemtura Recent Developments/Updates
Table 23. Lubrizol Basic Information, Manufacturing Base and Competitors
Table 24. Lubrizol Major Business
Table 25. Lubrizol Polyurethane Latex Product and Services
Table 26. Lubrizol Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Lubrizol Recent Developments/Updates
Table 28. Alberdingk Boley Basic Information, Manufacturing Base and Competitors
Table 29. Alberdingk Boley Major Business
Table 30. Alberdingk Boley Polyurethane Latex Product and Services
Table 31. Alberdingk Boley Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Alberdingk Boley Recent Developments/Updates
Table 33. Hauthaway Basic Information, Manufacturing Base and Competitors
Table 34. Hauthaway Major Business
Table 35. Hauthaway Polyurethane Latex Product and Services
Table 36. Hauthaway Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Hauthaway Recent Developments/Updates
Table 38. Stahl Basic Information, Manufacturing Base and Competitors
Table 39. Stahl Major Business
Table 40. Stahl Polyurethane Latex Product and Services
Table 41. Stahl Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Stahl Recent Developments/Updates
Table 43. Mitsui Chemicals Basic Information, Manufacturing Base and Competitors
Table 44. Mitsui Chemicals Major Business
Table 45. Mitsui Chemicals Polyurethane Latex Product and Services
Table 46. Mitsui Chemicals Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Mitsui Chemicals Recent Developments/Updates
Table 48. UBE Basic Information, Manufacturing Base and Competitors
Table 49. UBE Major Business
Table 50. UBE Polyurethane Latex Product and Services
Table 51. UBE Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. UBE Recent Developments/Updates
Table 53. DIC Basic Information, Manufacturing Base and Competitors
Table 54. DIC Major Business
Table 55. DIC Polyurethane Latex Product and Services
Table 56. DIC Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. DIC Recent Developments/Updates
Table 58. Reichhold Basic Information, Manufacturing Base and Competitors
Table 59. Reichhold Major Business
Table 60. Reichhold Polyurethane Latex Product and Services
Table 61. Reichhold Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Reichhold Recent Developments/Updates
Table 63. Wanhua Chemical Basic Information, Manufacturing Base and Competitors
Table 64. Wanhua Chemical Major Business
Table 65. Wanhua Chemical Polyurethane Latex Product and Services
Table 66. Wanhua Chemical Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. Wanhua Chemical Recent Developments/Updates
Table 68. Dow Chemical Basic Information, Manufacturing Base and Competitors
Table 69. Dow Chemical Major Business
Table 70. Dow Chemical Polyurethane Latex Product and Services
Table 71. Dow Chemical Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Dow Chemical Recent Developments/Updates
Table 73. SiwoChem Basic Information, Manufacturing Base and Competitors
Table 74. SiwoChem Major Business
Table 75. SiwoChem Polyurethane Latex Product and Services
Table 76. SiwoChem Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. SiwoChem Recent Developments/Updates
Table 78. SNP Basic Information, Manufacturing Base and Competitors
Table 79. SNP Major Business
Table 80. SNP Polyurethane Latex Product and Services
Table 81. SNP Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 82. SNP Recent Developments/Updates
Table 83. Chase Basic Information, Manufacturing Base and Competitors
Table 84. Chase Major Business
Table 85. Chase Polyurethane Latex Product and Services
Table 86. Chase Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 87. Chase Recent Developments/Updates
Table 88. VCM Polyurethanes Basic Information, Manufacturing Base and Competitors
Table 89. VCM Polyurethanes Major Business
Table 90. VCM Polyurethanes Polyurethane Latex Product and Services
Table 91. VCM Polyurethanes Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. VCM Polyurethanes Recent Developments/Updates
Table 93. Huntsman Corporation Basic Information, Manufacturing Base and Competitors
Table 94. Huntsman Corporation Major Business
Table 95. Huntsman Corporation Polyurethane Latex Product and Services
Table 96. Huntsman Corporation Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Huntsman Corporation Recent Developments/Updates
Table 98. OCSiAl Basic Information, Manufacturing Base and Competitors
Table 99. OCSiAl Major Business
Table 100. OCSiAl Polyurethane Latex Product and Services
Table 101. OCSiAl Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. OCSiAl Recent Developments/Updates
Table 103. Covestro Basic Information, Manufacturing Base and Competitors
Table 104. Covestro Major Business
Table 105. Covestro Polyurethane Latex Product and Services
Table 106. Covestro Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Covestro Recent Developments/Updates
Table 108. Global Polyurethane Latex Sales Quantity by Manufacturer (2021-2026) & (Tons)
Table 109. Global Polyurethane Latex Revenue by Manufacturer (2021-2026) & (USD Million)
Table 110. Global Polyurethane Latex Average Price by Manufacturer (2021-2026) & (US$/Ton)
Table 111. Market Position of Manufacturers in Polyurethane Latex, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 112. Head Office and Polyurethane Latex Production Site of Key Manufacturer
Table 113. Polyurethane Latex Market: Company Product Type Footprint
Table 114. Polyurethane Latex Market: Company Product Application Footprint
Table 115. Polyurethane Latex New Market Entrants and Barriers to Market Entry
Table 116. Polyurethane Latex Mergers, Acquisition, Agreements, and Collaborations
Table 117. Global Polyurethane Latex Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 118. Global Polyurethane Latex Sales Quantity by Region (2021-2026) & (Tons)
Table 119. Global Polyurethane Latex Sales Quantity by Region (2027-2032) & (Tons)
Table 120. Global Polyurethane Latex Consumption Value by Region (2021-2026) & (USD Million)
Table 121. Global Polyurethane Latex Consumption Value by Region (2027-2032) & (USD Million)
Table 122. Global Polyurethane Latex Average Price by Region (2021-2026) & (US$/Ton)
Table 123. Global Polyurethane Latex Average Price by Region (2027-2032) & (US$/Ton)
Table 124. Global Polyurethane Latex Sales Quantity by Type (2021-2026) & (Tons)
Table 125. Global Polyurethane Latex Sales Quantity by Type (2027-2032) & (Tons)
Table 126. Global Polyurethane Latex Consumption Value by Type (2021-2026) & (USD Million)
Table 127. Global Polyurethane Latex Consumption Value by Type (2027-2032) & (USD Million)
Table 128. Global Polyurethane Latex Average Price by Type (2021-2026) & (US$/Ton)
Table 129. Global Polyurethane Latex Average Price by Type (2027-2032) & (US$/Ton)
Table 130. Global Polyurethane Latex Sales Quantity by Application (2021-2026) & (Tons)
Table 131. Global Polyurethane Latex Sales Quantity by Application (2027-2032) & (Tons)
Table 132. Global Polyurethane Latex Consumption Value by Application (2021-2026) & (USD Million)
Table 133. Global Polyurethane Latex Consumption Value by Application (2027-2032) & (USD Million)
Table 134. Global Polyurethane Latex Average Price by Application (2021-2026) & (US$/Ton)
Table 135. Global Polyurethane Latex Average Price by Application (2027-2032) & (US$/Ton)
Table 136. North America Polyurethane Latex Sales Quantity by Type (2021-2026) & (Tons)
Table 137. North America Polyurethane Latex Sales Quantity by Type (2027-2032) & (Tons)
Table 138. North America Polyurethane Latex Sales Quantity by Application (2021-2026) & (Tons)
Table 139. North America Polyurethane Latex Sales Quantity by Application (2027-2032) & (Tons)
Table 140. North America Polyurethane Latex Sales Quantity by Country (2021-2026) & (Tons)
Table 141. North America Polyurethane Latex Sales Quantity by Country (2027-2032) & (Tons)
Table 142. North America Polyurethane Latex Consumption Value by Country (2021-2026) & (USD Million)
Table 143. North America Polyurethane Latex Consumption Value by Country (2027-2032) & (USD Million)
Table 144. Europe Polyurethane Latex Sales Quantity by Type (2021-2026) & (Tons)
Table 145. Europe Polyurethane Latex Sales Quantity by Type (2027-2032) & (Tons)
Table 146. Europe Polyurethane Latex Sales Quantity by Application (2021-2026) & (Tons)
Table 147. Europe Polyurethane Latex Sales Quantity by Application (2027-2032) & (Tons)
Table 148. Europe Polyurethane Latex Sales Quantity by Country (2021-2026) & (Tons)
Table 149. Europe Polyurethane Latex Sales Quantity by Country (2027-2032) & (Tons)
Table 150. Europe Polyurethane Latex Consumption Value by Country (2021-2026) & (USD Million)
Table 151. Europe Polyurethane Latex Consumption Value by Country (2027-2032) & (USD Million)
Table 152. Asia-Pacific Polyurethane Latex Sales Quantity by Type (2021-2026) & (Tons)
Table 153. Asia-Pacific Polyurethane Latex Sales Quantity by Type (2027-2032) & (Tons)
Table 154. Asia-Pacific Polyurethane Latex Sales Quantity by Application (2021-2026) & (Tons)
Table 155. Asia-Pacific Polyurethane Latex Sales Quantity by Application (2027-2032) & (Tons)
Table 156. Asia-Pacific Polyurethane Latex Sales Quantity by Region (2021-2026) & (Tons)
Table 157. Asia-Pacific Polyurethane Latex Sales Quantity by Region (2027-2032) & (Tons)
Table 158. Asia-Pacific Polyurethane Latex Consumption Value by Region (2021-2026) & (USD Million)
Table 159. Asia-Pacific Polyurethane Latex Consumption Value by Region (2027-2032) & (USD Million)
Table 160. South America Polyurethane Latex Sales Quantity by Type (2021-2026) & (Tons)
Table 161. South America Polyurethane Latex Sales Quantity by Type (2027-2032) & (Tons)
Table 162. South America Polyurethane Latex Sales Quantity by Application (2021-2026) & (Tons)
Table 163. South America Polyurethane Latex Sales Quantity by Application (2027-2032) & (Tons)
Table 164. South America Polyurethane Latex Sales Quantity by Country (2021-2026) & (Tons)
Table 165. South America Polyurethane Latex Sales Quantity by Country (2027-2032) & (Tons)
Table 166. South America Polyurethane Latex Consumption Value by Country (2021-2026) & (USD Million)
Table 167. South America Polyurethane Latex Consumption Value by Country (2027-2032) & (USD Million)
Table 168. Middle East & Africa Polyurethane Latex Sales Quantity by Type (2021-2026) & (Tons)
Table 169. Middle East & Africa Polyurethane Latex Sales Quantity by Type (2027-2032) & (Tons)
Table 170. Middle East & Africa Polyurethane Latex Sales Quantity by Application (2021-2026) & (Tons)
Table 171. Middle East & Africa Polyurethane Latex Sales Quantity by Application (2027-2032) & (Tons)
Table 172. Middle East & Africa Polyurethane Latex Sales Quantity by Country (2021-2026) & (Tons)
Table 173. Middle East & Africa Polyurethane Latex Sales Quantity by Country (2027-2032) & (Tons)
Table 174. Middle East & Africa Polyurethane Latex Consumption Value by Country (2021-2026) & (USD Million)
Table 175. Middle East & Africa Polyurethane Latex Consumption Value by Country (2027-2032) & (USD Million)
Table 176. Polyurethane Latex Raw Material
Table 177. Key Manufacturers of Polyurethane Latex Raw Materials
Table 178. Polyurethane Latex Typical Distributors
Table 179. Polyurethane Latex Typical Customers
Table 1. Global Polyurethane Latex Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Polyurethane Latex Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. BASF Basic Information, Manufacturing Base and Competitors
Table 4. BASF Major Business
Table 5. BASF Polyurethane Latex Product and Services
Table 6. BASF Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. BASF Recent Developments/Updates
Table 8. Bayer Basic Information, Manufacturing Base and Competitors
Table 9. Bayer Major Business
Table 10. Bayer Polyurethane Latex Product and Services
Table 11. Bayer Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Bayer Recent Developments/Updates
Table 13. DSM Basic Information, Manufacturing Base and Competitors
Table 14. DSM Major Business
Table 15. DSM Polyurethane Latex Product and Services
Table 16. DSM Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. DSM Recent Developments/Updates
Table 18. Chemtura Basic Information, Manufacturing Base and Competitors
Table 19. Chemtura Major Business
Table 20. Chemtura Polyurethane Latex Product and Services
Table 21. Chemtura Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Chemtura Recent Developments/Updates
Table 23. Lubrizol Basic Information, Manufacturing Base and Competitors
Table 24. Lubrizol Major Business
Table 25. Lubrizol Polyurethane Latex Product and Services
Table 26. Lubrizol Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Lubrizol Recent Developments/Updates
Table 28. Alberdingk Boley Basic Information, Manufacturing Base and Competitors
Table 29. Alberdingk Boley Major Business
Table 30. Alberdingk Boley Polyurethane Latex Product and Services
Table 31. Alberdingk Boley Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Alberdingk Boley Recent Developments/Updates
Table 33. Hauthaway Basic Information, Manufacturing Base and Competitors
Table 34. Hauthaway Major Business
Table 35. Hauthaway Polyurethane Latex Product and Services
Table 36. Hauthaway Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Hauthaway Recent Developments/Updates
Table 38. Stahl Basic Information, Manufacturing Base and Competitors
Table 39. Stahl Major Business
Table 40. Stahl Polyurethane Latex Product and Services
Table 41. Stahl Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Stahl Recent Developments/Updates
Table 43. Mitsui Chemicals Basic Information, Manufacturing Base and Competitors
Table 44. Mitsui Chemicals Major Business
Table 45. Mitsui Chemicals Polyurethane Latex Product and Services
Table 46. Mitsui Chemicals Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Mitsui Chemicals Recent Developments/Updates
Table 48. UBE Basic Information, Manufacturing Base and Competitors
Table 49. UBE Major Business
Table 50. UBE Polyurethane Latex Product and Services
Table 51. UBE Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. UBE Recent Developments/Updates
Table 53. DIC Basic Information, Manufacturing Base and Competitors
Table 54. DIC Major Business
Table 55. DIC Polyurethane Latex Product and Services
Table 56. DIC Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. DIC Recent Developments/Updates
Table 58. Reichhold Basic Information, Manufacturing Base and Competitors
Table 59. Reichhold Major Business
Table 60. Reichhold Polyurethane Latex Product and Services
Table 61. Reichhold Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Reichhold Recent Developments/Updates
Table 63. Wanhua Chemical Basic Information, Manufacturing Base and Competitors
Table 64. Wanhua Chemical Major Business
Table 65. Wanhua Chemical Polyurethane Latex Product and Services
Table 66. Wanhua Chemical Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. Wanhua Chemical Recent Developments/Updates
Table 68. Dow Chemical Basic Information, Manufacturing Base and Competitors
Table 69. Dow Chemical Major Business
Table 70. Dow Chemical Polyurethane Latex Product and Services
Table 71. Dow Chemical Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Dow Chemical Recent Developments/Updates
Table 73. SiwoChem Basic Information, Manufacturing Base and Competitors
Table 74. SiwoChem Major Business
Table 75. SiwoChem Polyurethane Latex Product and Services
Table 76. SiwoChem Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. SiwoChem Recent Developments/Updates
Table 78. SNP Basic Information, Manufacturing Base and Competitors
Table 79. SNP Major Business
Table 80. SNP Polyurethane Latex Product and Services
Table 81. SNP Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 82. SNP Recent Developments/Updates
Table 83. Chase Basic Information, Manufacturing Base and Competitors
Table 84. Chase Major Business
Table 85. Chase Polyurethane Latex Product and Services
Table 86. Chase Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 87. Chase Recent Developments/Updates
Table 88. VCM Polyurethanes Basic Information, Manufacturing Base and Competitors
Table 89. VCM Polyurethanes Major Business
Table 90. VCM Polyurethanes Polyurethane Latex Product and Services
Table 91. VCM Polyurethanes Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. VCM Polyurethanes Recent Developments/Updates
Table 93. Huntsman Corporation Basic Information, Manufacturing Base and Competitors
Table 94. Huntsman Corporation Major Business
Table 95. Huntsman Corporation Polyurethane Latex Product and Services
Table 96. Huntsman Corporation Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Huntsman Corporation Recent Developments/Updates
Table 98. OCSiAl Basic Information, Manufacturing Base and Competitors
Table 99. OCSiAl Major Business
Table 100. OCSiAl Polyurethane Latex Product and Services
Table 101. OCSiAl Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. OCSiAl Recent Developments/Updates
Table 103. Covestro Basic Information, Manufacturing Base and Competitors
Table 104. Covestro Major Business
Table 105. Covestro Polyurethane Latex Product and Services
Table 106. Covestro Polyurethane Latex Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Covestro Recent Developments/Updates
Table 108. Global Polyurethane Latex Sales Quantity by Manufacturer (2021-2026) & (Tons)
Table 109. Global Polyurethane Latex Revenue by Manufacturer (2021-2026) & (USD Million)
Table 110. Global Polyurethane Latex Average Price by Manufacturer (2021-2026) & (US$/Ton)
Table 111. Market Position of Manufacturers in Polyurethane Latex, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 112. Head Office and Polyurethane Latex Production Site of Key Manufacturer
Table 113. Polyurethane Latex Market: Company Product Type Footprint
Table 114. Polyurethane Latex Market: Company Product Application Footprint
Table 115. Polyurethane Latex New Market Entrants and Barriers to Market Entry
Table 116. Polyurethane Latex Mergers, Acquisition, Agreements, and Collaborations
Table 117. Global Polyurethane Latex Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 118. Global Polyurethane Latex Sales Quantity by Region (2021-2026) & (Tons)
Table 119. Global Polyurethane Latex Sales Quantity by Region (2027-2032) & (Tons)
Table 120. Global Polyurethane Latex Consumption Value by Region (2021-2026) & (USD Million)
Table 121. Global Polyurethane Latex Consumption Value by Region (2027-2032) & (USD Million)
Table 122. Global Polyurethane Latex Average Price by Region (2021-2026) & (US$/Ton)
Table 123. Global Polyurethane Latex Average Price by Region (2027-2032) & (US$/Ton)
Table 124. Global Polyurethane Latex Sales Quantity by Type (2021-2026) & (Tons)
Table 125. Global Polyurethane Latex Sales Quantity by Type (2027-2032) & (Tons)
Table 126. Global Polyurethane Latex Consumption Value by Type (2021-2026) & (USD Million)
Table 127. Global Polyurethane Latex Consumption Value by Type (2027-2032) & (USD Million)
Table 128. Global Polyurethane Latex Average Price by Type (2021-2026) & (US$/Ton)
Table 129. Global Polyurethane Latex Average Price by Type (2027-2032) & (US$/Ton)
Table 130. Global Polyurethane Latex Sales Quantity by Application (2021-2026) & (Tons)
Table 131. Global Polyurethane Latex Sales Quantity by Application (2027-2032) & (Tons)
Table 132. Global Polyurethane Latex Consumption Value by Application (2021-2026) & (USD Million)
Table 133. Global Polyurethane Latex Consumption Value by Application (2027-2032) & (USD Million)
Table 134. Global Polyurethane Latex Average Price by Application (2021-2026) & (US$/Ton)
Table 135. Global Polyurethane Latex Average Price by Application (2027-2032) & (US$/Ton)
Table 136. North America Polyurethane Latex Sales Quantity by Type (2021-2026) & (Tons)
Table 137. North America Polyurethane Latex Sales Quantity by Type (2027-2032) & (Tons)
Table 138. North America Polyurethane Latex Sales Quantity by Application (2021-2026) & (Tons)
Table 139. North America Polyurethane Latex Sales Quantity by Application (2027-2032) & (Tons)
Table 140. North America Polyurethane Latex Sales Quantity by Country (2021-2026) & (Tons)
Table 141. North America Polyurethane Latex Sales Quantity by Country (2027-2032) & (Tons)
Table 142. North America Polyurethane Latex Consumption Value by Country (2021-2026) & (USD Million)
Table 143. North America Polyurethane Latex Consumption Value by Country (2027-2032) & (USD Million)
Table 144. Europe Polyurethane Latex Sales Quantity by Type (2021-2026) & (Tons)
Table 145. Europe Polyurethane Latex Sales Quantity by Type (2027-2032) & (Tons)
Table 146. Europe Polyurethane Latex Sales Quantity by Application (2021-2026) & (Tons)
Table 147. Europe Polyurethane Latex Sales Quantity by Application (2027-2032) & (Tons)
Table 148. Europe Polyurethane Latex Sales Quantity by Country (2021-2026) & (Tons)
Table 149. Europe Polyurethane Latex Sales Quantity by Country (2027-2032) & (Tons)
Table 150. Europe Polyurethane Latex Consumption Value by Country (2021-2026) & (USD Million)
Table 151. Europe Polyurethane Latex Consumption Value by Country (2027-2032) & (USD Million)
Table 152. Asia-Pacific Polyurethane Latex Sales Quantity by Type (2021-2026) & (Tons)
Table 153. Asia-Pacific Polyurethane Latex Sales Quantity by Type (2027-2032) & (Tons)
Table 154. Asia-Pacific Polyurethane Latex Sales Quantity by Application (2021-2026) & (Tons)
Table 155. Asia-Pacific Polyurethane Latex Sales Quantity by Application (2027-2032) & (Tons)
Table 156. Asia-Pacific Polyurethane Latex Sales Quantity by Region (2021-2026) & (Tons)
Table 157. Asia-Pacific Polyurethane Latex Sales Quantity by Region (2027-2032) & (Tons)
Table 158. Asia-Pacific Polyurethane Latex Consumption Value by Region (2021-2026) & (USD Million)
Table 159. Asia-Pacific Polyurethane Latex Consumption Value by Region (2027-2032) & (USD Million)
Table 160. South America Polyurethane Latex Sales Quantity by Type (2021-2026) & (Tons)
Table 161. South America Polyurethane Latex Sales Quantity by Type (2027-2032) & (Tons)
Table 162. South America Polyurethane Latex Sales Quantity by Application (2021-2026) & (Tons)
Table 163. South America Polyurethane Latex Sales Quantity by Application (2027-2032) & (Tons)
Table 164. South America Polyurethane Latex Sales Quantity by Country (2021-2026) & (Tons)
Table 165. South America Polyurethane Latex Sales Quantity by Country (2027-2032) & (Tons)
Table 166. South America Polyurethane Latex Consumption Value by Country (2021-2026) & (USD Million)
Table 167. South America Polyurethane Latex Consumption Value by Country (2027-2032) & (USD Million)
Table 168. Middle East & Africa Polyurethane Latex Sales Quantity by Type (2021-2026) & (Tons)
Table 169. Middle East & Africa Polyurethane Latex Sales Quantity by Type (2027-2032) & (Tons)
Table 170. Middle East & Africa Polyurethane Latex Sales Quantity by Application (2021-2026) & (Tons)
Table 171. Middle East & Africa Polyurethane Latex Sales Quantity by Application (2027-2032) & (Tons)
Table 172. Middle East & Africa Polyurethane Latex Sales Quantity by Country (2021-2026) & (Tons)
Table 173. Middle East & Africa Polyurethane Latex Sales Quantity by Country (2027-2032) & (Tons)
Table 174. Middle East & Africa Polyurethane Latex Consumption Value by Country (2021-2026) & (USD Million)
Table 175. Middle East & Africa Polyurethane Latex Consumption Value by Country (2027-2032) & (USD Million)
Table 176. Polyurethane Latex Raw Material
Table 177. Key Manufacturers of Polyurethane Latex Raw Materials
Table 178. Polyurethane Latex Typical Distributors
Table 179. Polyurethane Latex Typical Customers
LIST OF FIGURES
Figure 1. Polyurethane Latex Picture
Figure 2. Global Polyurethane Latex Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Polyurethane Latex Revenue Market Share by Type in 2025
Figure 4. Water-based Polyurethane Emulsions Examples
Figure 5. Solvent-based Polyurethane Emulsions Examples
Figure 6. Global Polyurethane Latex Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Polyurethane Latex Revenue Market Share by Application in 2025
Figure 8. Electronic Components and Coatings Examples
Figure 9. Printing And Textile Industry Examples
Figure 10. Automotive And Aerospace Examples
Figure 11. Medical Equipment Examples
Figure 12. Other Examples
Figure 13. Global Polyurethane Latex Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 14. Global Polyurethane Latex Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 15. Global Polyurethane Latex Sales Quantity (2021-2032) & (Tons)
Figure 16. Global Polyurethane Latex Price (2021-2032) & (US$/Ton)
Figure 17. Global Polyurethane Latex Sales Quantity Market Share by Manufacturer in 2025
Figure 18. Global Polyurethane Latex Revenue Market Share by Manufacturer in 2025
Figure 19. Producer Shipments of Polyurethane Latex by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 20. Top 3 Polyurethane Latex Manufacturer (Revenue) Market Share in 2025
Figure 21. Top 6 Polyurethane Latex Manufacturer (Revenue) Market Share in 2025
Figure 22. Global Polyurethane Latex Sales Quantity Market Share by Region (2021-2032)
Figure 23. Global Polyurethane Latex Consumption Value Market Share by Region (2021-2032)
Figure 24. North America Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 25. Europe Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 26. Asia-Pacific Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 27. South America Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 28. Middle East & Africa Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 29. Global Polyurethane Latex Sales Quantity Market Share by Type (2021-2032)
Figure 30. Global Polyurethane Latex Consumption Value Market Share by Type (2021-2032)
Figure 31. Global Polyurethane Latex Average Price by Type (2021-2032) & (US$/Ton)
Figure 32. Global Polyurethane Latex Sales Quantity Market Share by Application (2021-2032)
Figure 33. Global Polyurethane Latex Revenue Market Share by Application (2021-2032)
Figure 34. Global Polyurethane Latex Average Price by Application (2021-2032) & (US$/Ton)
Figure 35. North America Polyurethane Latex Sales Quantity Market Share by Type (2021-2032)
Figure 36. North America Polyurethane Latex Sales Quantity Market Share by Application (2021-2032)
Figure 37. North America Polyurethane Latex Sales Quantity Market Share by Country (2021-2032)
Figure 38. North America Polyurethane Latex Consumption Value Market Share by Country (2021-2032)
Figure 39. United States Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 40. Canada Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 41. Mexico Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 42. Europe Polyurethane Latex Sales Quantity Market Share by Type (2021-2032)
Figure 43. Europe Polyurethane Latex Sales Quantity Market Share by Application (2021-2032)
Figure 44. Europe Polyurethane Latex Sales Quantity Market Share by Country (2021-2032)
Figure 45. Europe Polyurethane Latex Consumption Value Market Share by Country (2021-2032)
Figure 46. Germany Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 47. France Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 48. United Kingdom Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 49. Russia Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 50. Italy Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 51. Asia-Pacific Polyurethane Latex Sales Quantity Market Share by Type (2021-2032)
Figure 52. Asia-Pacific Polyurethane Latex Sales Quantity Market Share by Application (2021-2032)
Figure 53. Asia-Pacific Polyurethane Latex Sales Quantity Market Share by Region (2021-2032)
Figure 54. Asia-Pacific Polyurethane Latex Consumption Value Market Share by Region (2021-2032)
Figure 55. China Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 56. Japan Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 57. South Korea Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 58. India Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 59. Southeast Asia Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 60. Australia Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 61. South America Polyurethane Latex Sales Quantity Market Share by Type (2021-2032)
Figure 62. South America Polyurethane Latex Sales Quantity Market Share by Application (2021-2032)
Figure 63. South America Polyurethane Latex Sales Quantity Market Share by Country (2021-2032)
Figure 64. South America Polyurethane Latex Consumption Value Market Share by Country (2021-2032)
Figure 65. Brazil Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 66. Argentina Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 67. Middle East & Africa Polyurethane Latex Sales Quantity Market Share by Type (2021-2032)
Figure 68. Middle East & Africa Polyurethane Latex Sales Quantity Market Share by Application (2021-2032)
Figure 69. Middle East & Africa Polyurethane Latex Sales Quantity Market Share by Country (2021-2032)
Figure 70. Middle East & Africa Polyurethane Latex Consumption Value Market Share by Country (2021-2032)
Figure 71. Turkey Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 72. Egypt Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 73. Saudi Arabia Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 74. South Africa Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 75. Polyurethane Latex Market Drivers
Figure 76. Polyurethane Latex Market Restraints
Figure 77. Polyurethane Latex Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Polyurethane Latex in 2025
Figure 80. Manufacturing Process Analysis of Polyurethane Latex
Figure 81. Polyurethane Latex Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Polyurethane Latex Picture
Figure 2. Global Polyurethane Latex Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Polyurethane Latex Revenue Market Share by Type in 2025
Figure 4. Water-based Polyurethane Emulsions Examples
Figure 5. Solvent-based Polyurethane Emulsions Examples
Figure 6. Global Polyurethane Latex Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Polyurethane Latex Revenue Market Share by Application in 2025
Figure 8. Electronic Components and Coatings Examples
Figure 9. Printing And Textile Industry Examples
Figure 10. Automotive And Aerospace Examples
Figure 11. Medical Equipment Examples
Figure 12. Other Examples
Figure 13. Global Polyurethane Latex Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 14. Global Polyurethane Latex Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 15. Global Polyurethane Latex Sales Quantity (2021-2032) & (Tons)
Figure 16. Global Polyurethane Latex Price (2021-2032) & (US$/Ton)
Figure 17. Global Polyurethane Latex Sales Quantity Market Share by Manufacturer in 2025
Figure 18. Global Polyurethane Latex Revenue Market Share by Manufacturer in 2025
Figure 19. Producer Shipments of Polyurethane Latex by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 20. Top 3 Polyurethane Latex Manufacturer (Revenue) Market Share in 2025
Figure 21. Top 6 Polyurethane Latex Manufacturer (Revenue) Market Share in 2025
Figure 22. Global Polyurethane Latex Sales Quantity Market Share by Region (2021-2032)
Figure 23. Global Polyurethane Latex Consumption Value Market Share by Region (2021-2032)
Figure 24. North America Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 25. Europe Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 26. Asia-Pacific Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 27. South America Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 28. Middle East & Africa Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 29. Global Polyurethane Latex Sales Quantity Market Share by Type (2021-2032)
Figure 30. Global Polyurethane Latex Consumption Value Market Share by Type (2021-2032)
Figure 31. Global Polyurethane Latex Average Price by Type (2021-2032) & (US$/Ton)
Figure 32. Global Polyurethane Latex Sales Quantity Market Share by Application (2021-2032)
Figure 33. Global Polyurethane Latex Revenue Market Share by Application (2021-2032)
Figure 34. Global Polyurethane Latex Average Price by Application (2021-2032) & (US$/Ton)
Figure 35. North America Polyurethane Latex Sales Quantity Market Share by Type (2021-2032)
Figure 36. North America Polyurethane Latex Sales Quantity Market Share by Application (2021-2032)
Figure 37. North America Polyurethane Latex Sales Quantity Market Share by Country (2021-2032)
Figure 38. North America Polyurethane Latex Consumption Value Market Share by Country (2021-2032)
Figure 39. United States Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 40. Canada Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 41. Mexico Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 42. Europe Polyurethane Latex Sales Quantity Market Share by Type (2021-2032)
Figure 43. Europe Polyurethane Latex Sales Quantity Market Share by Application (2021-2032)
Figure 44. Europe Polyurethane Latex Sales Quantity Market Share by Country (2021-2032)
Figure 45. Europe Polyurethane Latex Consumption Value Market Share by Country (2021-2032)
Figure 46. Germany Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 47. France Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 48. United Kingdom Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 49. Russia Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 50. Italy Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 51. Asia-Pacific Polyurethane Latex Sales Quantity Market Share by Type (2021-2032)
Figure 52. Asia-Pacific Polyurethane Latex Sales Quantity Market Share by Application (2021-2032)
Figure 53. Asia-Pacific Polyurethane Latex Sales Quantity Market Share by Region (2021-2032)
Figure 54. Asia-Pacific Polyurethane Latex Consumption Value Market Share by Region (2021-2032)
Figure 55. China Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 56. Japan Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 57. South Korea Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 58. India Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 59. Southeast Asia Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 60. Australia Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 61. South America Polyurethane Latex Sales Quantity Market Share by Type (2021-2032)
Figure 62. South America Polyurethane Latex Sales Quantity Market Share by Application (2021-2032)
Figure 63. South America Polyurethane Latex Sales Quantity Market Share by Country (2021-2032)
Figure 64. South America Polyurethane Latex Consumption Value Market Share by Country (2021-2032)
Figure 65. Brazil Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 66. Argentina Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 67. Middle East & Africa Polyurethane Latex Sales Quantity Market Share by Type (2021-2032)
Figure 68. Middle East & Africa Polyurethane Latex Sales Quantity Market Share by Application (2021-2032)
Figure 69. Middle East & Africa Polyurethane Latex Sales Quantity Market Share by Country (2021-2032)
Figure 70. Middle East & Africa Polyurethane Latex Consumption Value Market Share by Country (2021-2032)
Figure 71. Turkey Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 72. Egypt Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 73. Saudi Arabia Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 74. South Africa Polyurethane Latex Consumption Value (2021-2032) & (USD Million)
Figure 75. Polyurethane Latex Market Drivers
Figure 76. Polyurethane Latex Market Restraints
Figure 77. Polyurethane Latex Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Polyurethane Latex in 2025
Figure 80. Manufacturing Process Analysis of Polyurethane Latex
Figure 81. Polyurethane Latex Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
